Veeva (VEEV) Systems announced that its board of directors approved a share repurchase program with authorization to purchase up to $2B of shares of its Class A common stock. “The breadth of our multi-product business, paired with a focus on operational discipline, innovation, and customer success, continues to drive financial outperformance and robust cash generation. This strength provides Veeva the healthy balance sheet to invest in the significant opportunities ahead and to return capital to shareholders. These ongoing investments in product excellence and the launch of our first ever share repurchase program reflect the confidence we have in our long-term growth trajectory and the enduring value we can deliver across the life sciences industry,” said CFO Brian Van Wagener.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VEEV:
- Salesforce Agentforce Life Sciences selected by Novartis
- Cognizant and Veeva’s Study on Nutrition and Bone Health: Key Insights for Investors
- Midday Fly By: Broadcom slides, pot stocks jump
- Roblox downgraded, Lululemon upgraded: Wall Street’s top analyst calls
- Veeva downgraded to Sector Weight from Overweight at KeyBanc
